Contributing factors to pediatric COVID-19 and MIS-C during the initial waves: A systematic review of 92 case reports

Muzna Sarfraz1, Azza Sarfraz2, Zouina Sarfraz3

  • 1CMH Lahore College, Lahore, Pakistan.

Insights

Pediatric COVID-19 cases were analyzed, identifying congenital defects and genetic factors as key contributors. Understanding these factors is crucial for managing pediatric COVID-19 and MIS-C.

Area of Science:

  • Pediatric Infectious Diseases
  • Epidemiology
  • Public Health

Background:

  • Coronavirus disease 2019 (COVID-19) has disproportionately affected adults compared to children.
  • Pediatric COVID-19 cases, though fewer, present unique challenges and contributing factors.
  • This study systematically reviews case reports to understand these pediatric-specific elements.

Purpose of the Study:

  • To identify and analyze the contributing factors for confirmed coronavirus disease 2019 (COVID-19) cases in the pediatric population.
  • To investigate factors associated with pediatric Multisystem Inflammatory Syndrome in Children (MIS-C).
  • To provide insights for future management and vaccination strategies for pediatric COVID-19.

Main Methods:

  • A systematic review of case reports was conducted.
  • Databases searched included PubMed and Cochrane Central between December 2019 and December 2020.
  • Keywords used were "pediatrics," "Case reports," "Cases," and "Covid-19."

Main Results:

  • A total of 92 records were analyzed, with 58% of patients being male and a mean age of 6.2 years.
  • Contributing factors for MIS-C included G6PD deficiency (17.6%) and Group A streptococcus co-infection (17.6%).
  • Factors for pediatric COVID-19 included congenital defects (18.5%), genetic defects (13.8%), and vertical/infancy transmission (16.9%).

Conclusions:

  • The pediatric population remains susceptible to COVID-19, especially with community transmission.
  • Identifying contributing factors like congenital issues and genetic predispositions is vital for pediatric COVID-19 and MIS-C.
  • These findings can inform guidelines for managing and potentially vaccinating children against COVID-19.
Abstract

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
485
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
20
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.8K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
465
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
314